Drug Interactions between minocycline and Singulair
This report displays the potential drug interactions for the following 2 drugs:
- minocycline
- Singulair (montelukast)
Interactions between your drugs
No interactions were found between minocycline and Singulair. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
minocycline
A total of 235 drugs are known to interact with minocycline.
- Minocycline is in the drug class tetracyclines.
-
Minocycline is used to treat the following conditions:
- Acne
- Actinomycosis
- Bacterial Infection
- Bartonellosis
- Brucellosis
- Bullous Pemphigoid
- Campylobacter Gastroenteritis
- Cholera
- Granuloma Inguinale
- Meningitis, Meningococcal
- Mycoplasma Pneumonia
- Ocular Rosacea
- Pemphigoid
- Pemphigus (off-label)
- Periodontitis
- Plague
- Psittacosis
- Q Fever
- Rabbit Fever
- Rheumatoid Arthritis (off-label)
- Rosacea (off-label)
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Trachoma
Singulair
A total of 117 drugs are known to interact with Singulair.
- Singulair is in the drug class leukotriene modifiers.
- Singulair is used to treat the following conditions:
Drug and food/lifestyle interactions
minocycline food/lifestyle
Applies to: minocycline
Consumer information for this interaction is not currently available.
GENERALLY AVOID: The oral bioavailability of quinolone and tetracycline antibiotics may be reduced by concurrent administration of preparations containing polyvalent cations such as aluminum, calcium, iron, magnesium, and zinc. Therapeutic failure may result. The proposed mechanism is chelation of quinolone and tetracycline antibiotics by di- and trivalent cations, forming an insoluble complex that is poorly absorbed from the gastrointestinal tract. Reduced gastrointestinal absorption of the cations should also be considered.
MANAGEMENT: Concomitant administration of oral quinolone and tetracycline antibiotics with preparations containing aluminum, calcium, iron, magnesium, and/or zinc salts should generally be avoided. Otherwise, the times of administration should be staggered by as much as possible to minimize the potential for interaction. Quinolones should typically be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation preparations, depending on the quinolone and formulation. Likewise, tetracyclines and polyvalent cation preparations should typically be administered 2 to 4 hours apart. The prescribing information for the antibiotic should be consulted for more specific dosing recommendations.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.